| Entry |
|
|---|
| Name |
Izonsteride (USAN/INN) |
|---|
| Formula |
C24H26N2OS2
|
|---|
| Exact mass |
422.1487
|
|---|
| Mol weight |
422.61
|
|---|
| Structure |
|
|---|
| Efficacy |
Antineoplastic, 5alpha-Reductase inhibitor |
|---|
| Comment |
Treatment of prostate cancer
Human type I and II isoforms of 5alpha-reductase inhibitor
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
SRD5A1
D04646 Izonsteride (USAN/INN)
SRD5A2
D04646 Izonsteride (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 29
1 C1x C 24.2900 -34.4400
2 C5x C 24.2900 -35.8400
3 N1y N 25.5024 -36.5400
4 C1y C 26.7149 -35.8400
5 C1z C 26.7149 -34.4400
6 C1x C 25.5024 -33.7400
7 C1x C 27.9273 -36.5400
8 C1x C 29.1397 -35.8400
9 C8y C 29.1397 -34.4400
10 C8y C 27.9273 -33.7400
11 C8x C 30.3522 -33.7400
12 C8y C 30.3522 -32.3400
13 C8x C 29.1397 -31.6400
14 C8x C 27.9273 -32.3400
15 S2a S 31.5853 -31.6278
16 C8y C 32.7915 -32.3240
17 N5x N 32.9396 -33.7284
18 C8y C 34.3210 -34.0216
19 C8y C 35.0267 -32.7984
20 S2x S 34.0815 -31.7492
21 C8y C 35.0214 -35.2338
22 C8x C 36.4214 -35.2334
23 C8x C 37.1271 -34.0102
24 C8x C 36.4267 -32.7980
25 C1a C 26.7149 -33.0400
26 O5x O 23.0776 -36.5400
27 C1b C 34.3267 -36.4375
28 C1a C 35.0341 -37.6621
29 C1a C 25.5024 -37.9400
BOND 33
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 2
11 5 10 1
12 9 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 10 14 1
17 12 15 1
18 15 16 1
19 16 17 2
20 17 18 1
21 18 19 1
22 19 20 1
23 16 20 1
24 18 21 2
25 21 22 1
26 22 23 2
27 23 24 1
28 19 24 2
29 5 25 1 #Up
30 2 26 2
31 21 27 1
32 27 28 1
33 3 29 1
|
|---|
